Expedia Group Welcomes New VP of Disability Inclusion

Zacks
Here is What to Know Beyond Why Altria Group, Inc. (MO) is a Trending Stock
Altria (MO) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
3h ago
MoneyWise
'Oh my God': This secretary in Illinois built a $7M fortune starting with $180. Here's the one powerful technique that made Grace Groner rich — and can change your life too
No lotto tickets required.
3h ago
TheStreet.com
No 'Guarantee' But Yellen May Have Just Set a Trap for the Bears
For once, Wall Street isn't blaming Powell for a market beatdown. Here's how I expect things to play out as we edge toward the end of March.
5h ago
Investor's Business Daily
Regeneron Breaks Out On Home Run In 'Smoker's Lung' As Sanofi Soars
Sanofi and Regeneron's asthma drug Dupixent succeeded in a study of patients with "smoker's lung," leading SNY and REGN stocks to rocket.
2h ago
Zacks
Medical Properties Trust, Inc. (MPW) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to Medical Properties (MPW). This makes it worthwhile to examine what the stock has in store.
3h ago
Yahoo Finance
Block stock falls 10% amid short seller accusations of 'inflated metrics' and 'avoiding regulation'
Block shares sank 20% after short seller Hindenburg Research said the digital payment company formally known as Square has "systematically taken advantage of the demographics it claims to be helping."
2h ago
SmartAsset
The Average 401(k) Balance by Age: Are You Off the Mark?
It can be hard to know if your retirement savings are on track, but comparing your balance to where others similar in age are can help. In particular, taking a look at the average 401(k) balance by age is a good place … Continue reading → The post The Average 401(k) Balance by Age: Are You Off the Mark? appeared first on SmartAsset Blog.
3h ago
Benzinga
Why Regeneron Pharmaceuticals And Sanofi Shares Are Trading Higher Today
Sanofi-Regeneron stocks are trading higher today after their blockbuster drug aced the pivotal COPD trial. Sanofi SA (NASDAQ: SNY) and Regeneron Pharmaceuticals Inc's (NASDAQ: REGN) Phase 3 trial of Dupixent (dupilumab) for uncontrolled chronic obstructive pulmonary disease (COPD) met its primary and secondary endpoints. Dupixent exhibited a 30% reduction in moderate or severe acute exacerbations compared to the placebo. The Phase 3 trial involving 939 current or former smokers also showed impro
3h ago
Zacks
Is It Worth Investing in NIO Inc. (NIO) Based on Wall Street's Bullish Views?
Based on the average brokerage recommendation (ABR), NIO Inc. (NIO) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
1d ago
Investor's Business Daily
Dow Jones Rises 300 Points After Surprise Drop In Jobless Claims; Block Crashes 22% On Short Seller Report
The Dow Jones rose Thursday after a surprise drop in first-time jobless claims. Block shares plunged 22% after a short seller report.
2h ago
TheStreet.com
Coinbase Announces Very Bad News
The cryptocurrency exchange says it received a warning from the Securities and Exchange Commission (SEC), suggesting a possible enforcement action.
5h ago
The Wall Street Journal
Charles Schwab Says It Could Ride Out a Deposit Flight
Charles Schwab , one of a host of financial firms that have taken a drubbing since the collapse of several regional banks this month, is pushing back against fears that it could face some of the same problems as paper losses on its bondholdings mount. In an interview with The Wall Street Journal, Schwab’s chief executive said the brokerage giant could continue to operate even if it lost most of its deposits over the next year. “There would be a sufficient amount of liquidity right there to cover if 100% of our bank’s deposits ran off,” said Walt Bettinger, Schwab’s co-chairman and CEO, referring to the company’s banking unit.
3h ago
Fortune
‘Gerbil banking’ preceded the Great Depression. We’re seeing it again today
Big banks are attracting more deposits–and putting money back into failing banks. A similar system existed in the run-up to the Great Depression.
6h ago
TipRanks
‘Load Up,’ Says Raymond James About These 3 ‘Strong Buy’ Stocks
The last few weeks have been rocky, with the collapse of Silicon Valley Bank, and the crypto-heavy Silvergate and Signature banks, dominating the headlines. For a short time, it seemed that the contagion would spread to the global financial giants. Now, however, it appears that we’ve managed to avoid a true banking crisis – and Raymond James’ chief investment officer Larry Adam has pointed out several reasons why. For starters, Adam notes that Credit Suisse, despite its troubles, found a way out
1d ago
Investor's Business Daily
Biogen Pops — But Ionis Hands Back Gains — After ALS Drug Wins A Key Endorsement
Biogen stock jumped — as Ionis stock gave back early gains — after a FDA panel offered a mixed view of their ALS treatment.
52m ago
TheStreet.com
As Bed Bath & Beyond Moves Out, Here Are the Names Moving Into Its Former Stores
In early February, Bed Bath & Beyond announced it would close 150 company stores. Since September, 2022, the Union, N.J.-based retailer has closed 400 stores in the U.S. altogether. In the retail sector, that kind of performance often leads to shuttered stores, and that's certainly the case with Bed, Bath & Beyond.
20h ago
Zacks
Cidara Therapeutics (CDTX) Reports Q4 Loss, Misses Revenue Estimates
Cidara Therapeutics (CDTX) delivered earnings and revenue surprises of -1,800% and 45.06%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
3h ago
MoneyWise
‘I would never put my money into a bank stock ever again’: Kevin O’Leary says the US government has ‘nationalized’ the American banking system. Here’s what he likes instead
Is the government doing more harm than good?
1d ago
SmartAsset
Ask an Advisor: I'm a 43-Year-Old Divorced Dad With $315K in an IRA, $90K in a Roth and Other Accounts. Can I Retire at 57?
I am a 43-year-old divorced father. I have $315,000 in a traditional individual retirement account (IRA), $90,000 in a Roth IRA, $22,000 in a health savings account (HSA), $8,000 in a 529 college savings account, $30,000 in a traditional 401k, … Continue reading → The post Ask an Advisor: I'm a 43-Year-Old Divorced Dad With $315K in an IRA, $90K in a Roth and Other Accounts. Can I Retire at 57? appeared first on SmartAsset Blog.
1d ago
SmartAsset
Does an Employer Match Count Toward My 401(k) Limit?
A 401(k) is an employer-sponsored, tax-advantaged retirement plan. You fund this account by contributing a set percentage of your paycheck into the account. One of the biggest perks of a 401(k) plan is that employers have the option to match your … Continue reading → The post How the Employer Match Works With the 401(k) Limit appeared first on SmartAsset Blog.
3h ago

Yahoo Finance

S&P 500

Dow 30

Nasdaq

Russell 2000

Crude Oil

Gold

Silver

EUR/USD

10-Yr Bond

Vix

GBP/USD

USD/JPY

BTC-USD

CMC Crypto 200

FTSE 100

Nikkei 225

Lawmakers say TikTok 'beholden' to Beijing as TikTok CEO Shou Chew testifies

Expedia Group Welcomes New VP of Disability Inclusion

Recommended Stories

Here is What to Know Beyond Why Altria Group, Inc. (MO) is a Trending Stock

'Oh my God': This secretary in Illinois built a $7M fortune starting with $180. Here's the one powerful technique that made Grace Groner rich — and can change your life too

No 'Guarantee' But Yellen May Have Just Set a Trap for the Bears

Regeneron Breaks Out On Home Run In 'Smoker's Lung' As Sanofi Soars

Medical Properties Trust, Inc. (MPW) is Attracting Investor Attention: Here is What You Should Know

Block stock falls 10% amid short seller accusations of 'inflated metrics' and 'avoiding regulation'

The Average 401(k) Balance by Age: Are You Off the Mark?

Why Regeneron Pharmaceuticals And Sanofi Shares Are Trading Higher Today

Is It Worth Investing in NIO Inc. (NIO) Based on Wall Street's Bullish Views?

Dow Jones Rises 300 Points After Surprise Drop In Jobless Claims; Block Crashes 22% On Short Seller Report

Coinbase Announces Very Bad News

Charles Schwab Says It Could Ride Out a Deposit Flight

‘Gerbil banking’ preceded the Great Depression. We’re seeing it again today

‘Load Up,’ Says Raymond James About These 3 ‘Strong Buy’ Stocks

Biogen Pops — But Ionis Hands Back Gains — After ALS Drug Wins A Key Endorsement

As Bed Bath & Beyond Moves Out, Here Are the Names Moving Into Its Former Stores

Cidara Therapeutics (CDTX) Reports Q4 Loss, Misses Revenue Estimates

‘I would never put my money into a bank stock ever again’: Kevin O’Leary says the US government has ‘nationalized’ the American banking system. Here’s what he likes instead

Ask an Advisor: I'm a 43-Year-Old Divorced Dad With $315K in an IRA, $90K in a Roth and Other Accounts. Can I Retire at 57?

Does an Employer Match Count Toward My 401(k) Limit?